Skip to main content
HCPCS J1610 · Level II · Part B drug

J1610: glucagon hydrochloride, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1610

Billing unit
1 MG
Glucagon hydrochloride/1 mg
ASP payment limit
$105.492
October 2026; -10.1% vs July 2026
Practitioner MUE
2
MAI 3
OPPS status
SI K
APC 9042
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1610 is the Level II code for Injection, glucagon hydrochloride, per 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $105.492 per billing unit, down 10.1% from July 2026. The practitioner MUE allows up to 2 units per date of service (MAI 3), so a full 2-unit day is $210.98 at the current limit. Under OPPS it carries status indicator K in APC 9042. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names glucagon: J1611 (the Fresenius Kabi product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J1610); J1612 (Gvoke Vialdx from American Regent, Inc.; billed per 0.01 mg). The ASP crosswalk maps 5 NDCs to it, sold as Glucagon, Glucagon Emergency by Novo Nordisk, Inc., Mylan Pharmaceuticals Inc., Amphastar Pharmaceuticals, Inc. No current Billing and Coding Article lists J1610, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1610 at $105.492 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $117.331 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1610
QuarterPayment limitPerCoinsurance
October 2026$105.4921 MG20%
July 2026$117.3311 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 5 NDCs from 5 labelers to J1610. Report the NDC in the claim's drug segment and bill the number of J1610 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J1610
NDCDrug nameLabelerPackage sizeBilling units / package
00169-7065-15GlucagonNovo Nordisk, Inc.1 × 11
00378-8067-90GlucagonMylan Pharmaceuticals Inc.1 × 11
00548-5850-00GlucagonAmphastar Pharmaceuticals, Inc.1 × 11
50090-6550-00Glucagon EmergencyA-S Medication Solutions1 × 11
69097-0027-50Glucagon EmergencyCipla Usa, Inc.1 × 11

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1610. For practitioners the limit is 2 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1610 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services23 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital33 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1610 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1610 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1610 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1610 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1610 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1610 carries status indicator K and is assigned to APC 9042, with a published national unadjusted payment of $105.492. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1610 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $105.49 per 1 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1610 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1610

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1610

What does HCPCS code J1610 describe?

J1610 is defined by CMS as "Injection, glucagon hydrochloride, per 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1610 a CPT code?

No. J1610 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as glucagon hydrochloride; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1610 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1610 in October 2026?

The ASP-based payment limit is $105.492 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $117.331. Commercial payers use their own fee schedules.

How many units of J1610 can be billed per day?

The practitioner Medically Unlikely Edit is 2 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 3. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1610?

The October 2026 ASP crosswalk lists 5 NDCs from 5 labelers: Glucagon (Novo Nordisk, Inc.); Glucagon (Mylan Pharmaceuticals Inc.); Glucagon (Amphastar Pharmaceuticals, Inc.); Glucagon Emergency (A-S Medication Solutions). For example NDC 00169-7065-15 (package size 1) equals 1 billing unit of J1610.

Does J1610 have NCCI bundling edits?

No active practitioner PTP pairs list J1610 as a column-1 or column-2 code in the v323r0 release.

J1610 vs J1611: what is the difference?

Both are HCPCS Level II codes whose descriptor names glucagon hydrochloride. What sets J1611 apart: the Fresenius Kabi product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J1610. J1610 is billed per 1 mg, limit $105.492, MUE 2; J1611 is billed per 1 mg, limit $134.892, MUE 2. Report the code whose descriptor matches the product and setting in the record.

J1610 vs J1612: what is the difference?

Both are HCPCS Level II codes whose descriptor names glucagon. What sets J1612 apart: Gvoke Vialdx from American Regent, Inc.; billed per 0.01 mg. J1610 is billed per 1 mg, limit $105.492, MUE 2; J1612 is billed per 0.01 mg, limit $1.799. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.